Topiramate is an anticonvulsant licensed in the UK for epilepsy and migraine prevention, and although weight loss can occur as a side effect, it is not licensed for weight management and carries significant neurological, metabolic, and pregnancy-related risks
People value having a transparent overview that prevents confusion
It may promote liver detoxification while helping to strengthen both immune function and cellular health
For an additional regulator-backed drug label reference, see DailyMeds Janumet label
Iannuzzi et al., encompassing 44 studies conducted between 1961 and 2016, revealed that the overall incidence of AP across Asia has remained relatively stable, with an annual change of only 0.28%
The medication may still be fine, or it may have degraded past the point of effectiveness